206 related articles for article (PubMed ID: 1985691)
1. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
3. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.
Fischer A; Griscelli C; Friedrich W; Kubanek B; Levinsky R; Morgan G; Vossen J; Wagemaker G; Landais P
Lancet; 1986 Nov; 2(8515):1080-4. PubMed ID: 2877234
[TBL] [Abstract][Full Text] [Related]
4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.
Cavazzana-Calvo M; Bordigoni P; Michel G; Esperou H; Souillet G; Leblanc T; Stephan JL; Vannier JP; Mechinaud F; Reiffers J; Vilmer E; Landman-Parker J; Benkerrou M; Baruchel A; Pico J; Bernaudin F; Bergeron C; Plouvier E; Thomas C; Wijdenes J; Lacour B; Blanche S; Fischer A
Br J Haematol; 1996 Apr; 93(1):131-8. PubMed ID: 8611446
[TBL] [Abstract][Full Text] [Related]
6. In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.
Cavazzana-Calvo M; Jabado N; Bordigoni P; Michel G; Haddad E; Mechinaud F; Landman-Parker J; Leblanc T; Plouvier E; Baruchel A; Stephan JL; Souillet G; Vilmer E; Wijdenes J; Le Deist F; Fischer A
Leuk Lymphoma; 1997 Dec; 28(1-2):103-12. PubMed ID: 9498709
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.
Rumelhart SL; Trigg ME; Horowitz SD; Hong R
Blood; 1990 Feb; 75(4):1031-5. PubMed ID: 2302455
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency.
Fischer A; Landais P; Friedrich W; Gerritsen B; Fasth A; Porta F; Vellodi A; Benkerrou M; Jais JP; Cavazzana-Calvo M
Blood; 1994 Feb; 83(4):1149-54. PubMed ID: 8111055
[TBL] [Abstract][Full Text] [Related]
9. Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation.
Fischer A; Griscelli C; Blanche S; Le Deist F; Veber F; Lopez M; Delaage M; Olive D; Mawas C; Janossy G
Lancet; 1986 Nov; 2(8515):1058-61. PubMed ID: 2877223
[TBL] [Abstract][Full Text] [Related]
10. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors.
Jabado N; de Graeff-Meeder ER; Cavazzana-Calvo M; Haddad E; Le Deist F; Benkerrou M; Dufourcq R; Caillat S; Blanche S; Fischer A
Blood; 1997 Dec; 90(12):4743-8. PubMed ID: 9389690
[TBL] [Abstract][Full Text] [Related]
11. Unrelated donor marrow transplantation for congenital immunodeficiency and metabolic disease: an update of the experience of the Japan Marrow Donor Program.
Sakata N; Kawa K; Kato K; Yabe H; Yabe M; Nagasawa M; Mugishima H; Kigasawa H; Tsuchida M; Akiyama Y; Morisima Y; Kodera Y; Kato S
Int J Hematol; 2004 Aug; 80(2):174-82. PubMed ID: 15481448
[TBL] [Abstract][Full Text] [Related]
12. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
Knutsen AP; Wall DA
J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89.
Hows JM; Chapple M; Marsh JC; Durrant S; Yin JL; Swirsky D; Gordon-Smith EC
Bone Marrow Transplant; 1989 Nov; 4(6):629-34. PubMed ID: 2684308
[TBL] [Abstract][Full Text] [Related]
14. In vivo infusion of anti LFA-1 antibody in HLA non-identical bone marrow transplantation in children: serum concentrations and biological effects.
Perez N; Le Deist F; Chatenoud L; Chanteloup N; Griscelli C; Fischer A
Bone Marrow Transplant; 1989 Jul; 4(4):379-84. PubMed ID: 2673457
[TBL] [Abstract][Full Text] [Related]
15. Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency.
Wijnaendts L; Le Deist F; Griscelli C; Fischer A
Blood; 1989 Nov; 74(6):2212-9. PubMed ID: 2804359
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group.
Gerritsen EJ; Vossen JM; Fasth A; Friedrich W; Morgan G; Padmos A; Vellodi A; Porras O; O'Meara A; Porta F
J Pediatr; 1994 Dec; 125(6 Pt 1):896-902. PubMed ID: 7996361
[TBL] [Abstract][Full Text] [Related]
17. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
[TBL] [Abstract][Full Text] [Related]
18. HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.
Giri N; Vowels M; Ziegler JB; Ford D; Lam-Po-Tang R
Aust N Z J Med; 1994 Feb; 24(1):26-30. PubMed ID: 8002854
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
[TBL] [Abstract][Full Text] [Related]
20. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.
Filipovich AH; Shapiro RS; Ramsay NK; Kim T; Blazar B; Kersey J; McGlave P
Blood; 1992 Jul; 80(1):270-6. PubMed ID: 1611094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
